Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • GENERAL HEALTH CARE NEWS—S.D.N.Y.: TV program critique of MCO and its CEO was not defamation
    • ADMINISTRATION OF FDC ACT—NOTICES: Importer of controlled substances application: CalCog Inc.
    • ADMINISTRATION OF FDC ACT—NOTICES: Protamine sulfate intravenous solution, 50 Milligrams/5 Milliliters, not withdrawn from sale
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—DAB DECISIONS: 5-year exclusion upheld in Medicaid fraud personal care billing scheme
    • COSMETICS—FINAL RULES: FDA expands list of permitted sunscreen ingredients
    • EXPERT INSIGHTS—Jurisdiction Under Scrutiny In OPO Challenge To 2020 Final Rule
    • FALSE CLAIMS ACT—D. Ariz.: Court denied in part motion to dismiss ENT health care center in a false claims action
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Health Law Daily Wrap Up, ADMINISTRATION OF FDC ACT—NOTICES: Importer of controlled substances application: CalCog Inc., (Jun 10, 2026)

    By WK Editorial Staff

    Authorization will not extend to the import of FDA-approved or non-approved finished dosage forms for commercial sale.

    CalCog Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). The company plans to import t ...

    By WK Editorial Staff

    Authorization will not extend to the import of FDA-approved or non-approved finished dosage forms for commercial sale.

    CalCog Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). The company plans to import the above listed controlled substance(s) as dosage units for clinical trials only. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2) (Notice, 91 Fed. Reg. 34654 (June 8, 2026)).

    Dates. Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 8, 2026.

    FederalRegisterIssuances: Notices ControlledNews DrugBiologicNews PrescriptionDrugNews SafetyNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use